🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
First-in-human, Phase 1b/2 safety study of the antibody-drug conjugate (ADC...
Status
Completed
Location
University of Oklahoma
Start Date
2019-07-30
Trial ID
NCT06517485
Treatments Being Tested
First-in-human, Phase 1b/2 safety study of the antibody-drug conjugate (ADC...
Status
Active Not Recruiting
Location
University of Oklahoma
Start Date
2017-12-12
Trial ID
NCT03319628
Treatments Being Tested
UP-NEXT is a double-blind, randomized, placebo-controlled study of the anti...
Status
Terminated
Location
HonorHealth Research Institute - HonorHealth VGPCC Biltmore
Start Date
2022-06-23
Trial ID
NCT05329545
Treatments Being Tested
First-in-human, Phase 1b/2 safety study of the antibody-drug conjugate (ADC...
Status
Completed
Location
University of Oklahoma
Start Date
2017-12-12
Trial ID
NCT06517433
Treatments Being Tested
Phase 1 safety study of the antibody-drug conjugate (ADC) XMT-1536 (upifita...
Status
Terminated
Location
START Midwest
Start Date
2021-06-11
Trial ID
NCT04907968
Treatments Being Tested